KR20020062300A - 염분-의존성 고혈압 치료에 있어서 도파민―d3 수용체아고니스트의 용도 - Google Patents

염분-의존성 고혈압 치료에 있어서 도파민―d3 수용체아고니스트의 용도 Download PDF

Info

Publication number
KR20020062300A
KR20020062300A KR1020027005750A KR20027005750A KR20020062300A KR 20020062300 A KR20020062300 A KR 20020062300A KR 1020027005750 A KR1020027005750 A KR 1020027005750A KR 20027005750 A KR20027005750 A KR 20027005750A KR 20020062300 A KR20020062300 A KR 20020062300A
Authority
KR
South Korea
Prior art keywords
dopamine
rats
salt
hypertension
receptor
Prior art date
Application number
KR1020027005750A
Other languages
English (en)
Korean (ko)
Inventor
베른트 뭘바우어
Original Assignee
애보트 게엠베하 운트 콤파니 카게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 애보트 게엠베하 운트 콤파니 카게 filed Critical 애보트 게엠베하 운트 콤파니 카게
Publication of KR20020062300A publication Critical patent/KR20020062300A/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020027005750A 1999-11-04 2000-10-31 염분-의존성 고혈압 치료에 있어서 도파민―d3 수용체아고니스트의 용도 KR20020062300A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19953254.0 1999-11-04
DE19953254 1999-11-04
PCT/EP2000/010770 WO2001032263A1 (fr) 1999-11-04 2000-10-31 Utilisation d'antagonistes du recepteur d3 de la dopamine pour la therapie de l'hypertonie liee a l'absorption de sel

Publications (1)

Publication Number Publication Date
KR20020062300A true KR20020062300A (ko) 2002-07-25

Family

ID=7928007

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020027005750A KR20020062300A (ko) 1999-11-04 2000-10-31 염분-의존성 고혈압 치료에 있어서 도파민―d3 수용체아고니스트의 용도

Country Status (15)

Country Link
EP (1) EP1233815A1 (fr)
JP (1) JP2003513053A (fr)
KR (1) KR20020062300A (fr)
CN (1) CN1387450A (fr)
AU (1) AU1390801A (fr)
BR (1) BR0015310A (fr)
CA (1) CA2389643A1 (fr)
CZ (1) CZ20021521A3 (fr)
HU (1) HUP0203024A2 (fr)
IL (1) IL149266A0 (fr)
MX (1) MXPA02004103A (fr)
NO (1) NO20022142D0 (fr)
RU (1) RU2002114818A (fr)
WO (1) WO2001032263A1 (fr)
ZA (1) ZA200204455B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1180599A1 (fr) * 2000-08-16 2002-02-20 Siemens Building Technologies AG Dispositif de sécurité pour une pompe pouvant être utilisée dans une transmission à fluide
JP2010184889A (ja) * 2009-02-12 2010-08-26 Nihon Univ 高血圧症予防治療薬
WO2011047350A2 (fr) * 2009-10-16 2011-04-21 David Helton Traitement des vomissements

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008219A (en) * 1995-03-27 1999-12-28 Smithkline Beech P.L.C. Bicyclic amine derivatives and their use as anti-psychotic agents
FR2742149B1 (fr) * 1995-12-11 1998-02-13 Inst Nat Sante Rech Med Nouveaux derives de 2-naphtamides et leurs applications therapeutiques

Also Published As

Publication number Publication date
HUP0203024A2 (hu) 2003-02-28
IL149266A0 (en) 2002-11-10
AU1390801A (en) 2001-05-14
NO20022142L (no) 2002-05-03
NO20022142D0 (no) 2002-05-03
ZA200204455B (en) 2003-09-04
CN1387450A (zh) 2002-12-25
EP1233815A1 (fr) 2002-08-28
MXPA02004103A (es) 2003-08-20
WO2001032263A1 (fr) 2001-05-10
RU2002114818A (ru) 2004-01-10
JP2003513053A (ja) 2003-04-08
BR0015310A (pt) 2002-07-09
CA2389643A1 (fr) 2001-05-10
CZ20021521A3 (cs) 2003-05-14

Similar Documents

Publication Publication Date Title
KR100650962B1 (ko) 질소산화물합성효소(nos)의기능저하에의해유발되는질환의예방또는치료제
KR101996245B1 (ko) 선택적 s1p1 수용체 아고니스트를 포함하는 약학 조합물
JPH0621070B2 (ja) ジアゼピン含有医薬組成物
EP1379242B1 (fr) Methode de traitement de cancers et compositions appropriees
RU2462249C2 (ru) Терапевтические композиции, содержащие специфический антагонист рецептора эндотелина и ингибитор pde5
ES2425482T3 (es) Antagonista del receptor de angiotensina II para el tratamiento de enfermedades sistémicas en gatos
TW201936567A (zh) 發炎性疾病或骨病之預防或治療劑及醫藥組成物
US20050239759A1 (en) Method of treatment of disease using an adenosine A1 receptor antagonist and an aldosterone inhibitor
WO2006118212A1 (fr) Agent de prevention et de traitement des pancreatites
Purkerson et al. Tubular reabsorption of phosphate after release of complete ureteral obstruction in the rat
KR20020062300A (ko) 염분-의존성 고혈압 치료에 있어서 도파민―d3 수용체아고니스트의 용도
US20110281852A1 (en) Pharmaceutical compositions containing berberine for treatment or prevention of weight gain and obesity associated with anti-psychotic drugs
Fowler Jr et al. Renin-angiotensin mechanisms in oral contraceptive hypertension in conscious rats
Yü et al. Effect of a phenylbutazone analog (4-[phenylthioethyl]-1, 2-diphenyl 3, 5-pyrazolidinedione) on urate clearance and other discrete renal functions in gouty subjects. Evaluation as uricosuric agent
EP1698348A1 (fr) Remede curatif ou preventif des troubles vasculaires et de l'hypertension et son procede de criblage
JP2002506463A (ja) 利尿機能および腎機能を回復するためのアデノシンa1レセプターアンタゴニスト含有組成物および方法
JP2006509782A (ja) 疼痛、片頭痛および尿失禁の治療における4−フェニル−置換テトラヒドロイソキノリンの使用
Langård et al. Conditions for stimulation of renin release by cyclic AMP in anaesthetized dogs
Shid Moosavi et al. Effect of Endothelin-A Receptor Blockade on the Early Phase of Ischemia/Reperfusion-Induced Acute Renal Failure in Anesthetized Rats
JP5360933B2 (ja) ニトロソニフェジピン誘導体を有効成分とする糖尿病性腎症治療剤
JPH10324625A (ja) 血管内皮増殖因子阻害剤
JP6090723B2 (ja) 腎機能障害の予防又は改善剤
EP4440572A1 (fr) Traitement de la polyarthrite rhumatoïde
CN117731721A (zh) 植物提取物组合物及其应用
AU2002245927B2 (en) Method for treatment of cancer and compositions for use therein

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid